Myoinositol supplementation in the treatment of gestational diabetes mellitus: effects on glycaemic control and maternal-foetal outcomes

BACKGROUND: Gestational diabetes mellitus (GDM) is defined as glucose intolerance with onset during pregnancy. It is characterized by high risk of adverse outcomes for the mother and the foetus, if not adequately controlled. The aim of the study was to evaluate the effects of 4000 mg of myoinositol...

Descripción completa

Detalles Bibliográficos
Autores principales: Guarnotta, Valentina, Cuva, Gianluca, Imbergamo, Maria Pia, Giordano, Carla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9233779/
https://www.ncbi.nlm.nih.gov/pubmed/35754028
http://dx.doi.org/10.1186/s12884-022-04852-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9233779/
https://www.ncbi.nlm.nih.gov/pubmed/35754028
http://dx.doi.org/10.1186/s12884-022-04852-3

Ejemplares similares